Format

Send to

Choose Destination
See comment in PubMed Commons below
Respir Med. 2004 Sep;98(9):892-7.

Role of siroliumus, a novel immunosuppressive drug in heart and lung transplantation.

Author information

1
Pulmonary Institute, Rabin Medical Center, School of Medicine, Beilinson Campus, Tel Aviv University, Petah Tiqwa and Sackler Tel Aviv, Israel. davids3@clalit.org.il

Abstract

Lung and heart transplantation has become an accepted therapeutic option for patients with end-stage disease. However, the calcineurin-inhibitor-based immunosuppression often causes renal impairment. Therefore, sirolimus, a novel immunosuppressive agent, may serve as an alternative or complementary agent to calcineurin inhibitors. The aim of this review was to summarize the role of sirolimus in lung and heart transplantation. Although only a few, small studies have been conducted so far, the drug's mechanisms of action and low-toxicity profile make it a highly promising option.

PMID:
15338803
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center